window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : May 13, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Digital & Data

  • Digital & Data,Therapeutic Areas

    Insilico nominates pan-KRAS candidate ISM6166 after tumour regression in preclinical studies

    Insilico Medicine has nominated ISM6166 as a preclinical candidate, positioning [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Therapeutic Areas

    SPT Labtech and Illumina to develop automated platform for decentralised oncology genomics

    SPT Labtech has entered a strategic collaboration with Illumina to [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Opinion & Events,Therapeutic Areas

    Young adults in US, UK and Australia hit hardest by global mental health decline

    Young adults in wealthy countries are four times more likely [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Delivery & Formulation,Therapeutic Areas

    Study confirms Nerivio REN wearable safe with continuous glucose monitoring devices

    A new study confirms that Theranica’s Nerivio REN wearable for [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Pharmaceuticals and therapeutics

    Brainomix extends Series C to $25.4M to support US expansion

    Brainomix has extended its Series C financing by $6.5M (£4.8M), [...]

    May 5, 2026
  • Digital & Data,Drug Discovery & Development

    Promise Bio launches grant to support translational epiproteomics in biotech research

    Promise Bio has launched the Frontier Epiproteomic Innovation Grant, providing [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    Evinova secures collaborations with Astellas, AstraZeneca and Bristol Myers Squibb to share clinical trial data for AI benchmarking

    Evinova has announced collaborations with Astellas Pharma, AstraZeneca and Bristol [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Therapeutic Areas

    Evogene partners QUT on AI drug discovery for lung cancer resistance

    Evogene Ltd has partnered with Queensland University of Technology to [...]

    May 5, 2026
  • Digital & Data,Drug Discovery & Development,Pharmaceuticals and therapeutics

    Within3 launches Dataverse to integrate real-world data into pharma launch intelligence platform

    Within3 has launched Dataverse, a partner ecosystem designed to extend [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Pharmaceuticals and therapeutics

    AI and medical affairs strategy set to redefine life sciences in 2026

    Artificial intelligence, shifting healthcare professional behaviour and rising pressure on [...]

    May 5, 2026
Previous234Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Neomorph raises $100 million to advance NEO-811 Phase 1/2 cancer trial and molecular glue degrader pipeline
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Therapeutic Areas
  • NICE expands Lokelma access for hyperkalaemia after draft recommendation
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
  • Oncodesign expands ARRONAX deal to secure astatine-211 supply for radiotherapy research
    Categories: Biotech & Pharma Business, Drug Discovery & Development, Manufacturing & Supply Chain, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top